Home LiteratureArticle Details
PMID: 11337030 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Death the Fas way: regulation and pathophysiology of CD95 and its ligand.

Pharmacology & therapeutics ·Vol. 88 ·No. 3 ·2000-12-00 ·Pages 333-47

Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, Shi YF

Abstract

Apoptotic cell death mediated by the members of the tumor necrosis factor receptor family is an essential process involved in the regulation of cellular homeostasis during development, differentiation, and pathophysiological conditions. Among the cell death receptors comprising the tumor necrosis factor receptor superfamily, CD95/APO-1 (Fas) is the best characterized. The specific interaction of Fas with its cognate ligand, Fas ligand (FasL), elicits the activation of a death-inducing caspase (cysteine aspartic acid proteases) cascade, occurring in a transcription-independent manner. Caspase activation executes the apoptosis process by cleaving various intracellular substrates, leading to genomic DNA fragmentation, cell membrane blebbing, and the exposure of phagocytosis signaling molecules on the cell surface. Recent studies have shown that the Fas/FasL pathway plays an important role in regulating the life and death of the immune system through activation-induced cell death. In addition, these molecules have been implicated in aging, human immunodeficiency virus infection, drug abuse, stress, and cancer development. In this review, we will focus on the mechanisms that regulate Fas and FasL expression, and how their deregulation leads to diseases.

MeSH Terms
Aging Anxiety Disorders Apoptosis Blister Cell Membrane DNA Damage Fas Ligand Protein HIV Infections/physiopathology Humans Membrane Glycoproteins/biosynthesis,immunology,pharmacology Neoplasms/physiopathology Phagocytosis Receptors, Tumor Necrosis Factor/immunology,physiology Signal Transduction Substance-Related Disorders Transcription, Genetic Up-Regulation fas Receptor/biosynthesis,immunology,pharmacology
Chemicals
FASLG protein, human Fas Ligand Protein Membrane Glycoproteins Receptors, Tumor Necrosis Factor fas Receptor
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Sharma K
Department of Immunology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA.
Wang R X
Zhang L Y
Yin D L
Luo X Y
Solomon J C
Jiang R F
Markos K
Davidson W
Scott D W
Shi Y F
Article Info
Journal
Pharmacology & therapeutics
Abbr.
Pharmacol Ther
ISSN
0163-7258
Published
2000-12-00
Pages
333-47
Language
English
Region
England
NLM ID
7905840
Subset
IM
Grants
NIAID NIH HHS · AI43384-02 · United States
NCI NIH HHS · CA53609 · United States
NCI NIH HHS · CA76492 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]